Targeting of EWS-FLI1 as anti-tumor therapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9758481
APP PUB NO 20150329488A1
SERIAL NO

14696005

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Peptides and compounds are provided that function as EWS-FLI1 protein inhibitors. The peptides and compounds have utility in the treatment of Ewing's sarcoma family of tumors. Also provided are methods of preparing the compounds and assays for identifying inhibitors of EWS-FLI1 protein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GEORGETOWN UNIVERSITY37TH AND O STREETS N W WASHINGTON DC 20057

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Brown, Milton Lang Brookville, US 6 128
Kong, Yali Centerville, US 15 153
Toretsky, Jeffrey A Silver Spring, US 9 187
Uren, Aykut Rockville, US 14 147

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 12, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 12, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00